DrugPatentWatch Database Preview
Actavis Labs Fl Company Profile
What is the competitive landscape for ACTAVIS LABS FL, and what generic and branded alternatives to ACTAVIS LABS FL drugs are available?
ACTAVIS LABS FL has seventy-seven approved drugs.
There are two tentative approvals on ACTAVIS LABS FL drugs.
Summary for Actavis Labs Fl
| US Patents: | 0 |
| Tradenames: | 61 |
| Ingredients: | 59 |
| NDAs: | 77 |
Drugs and US Patents for Actavis Labs Fl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 077686-002 | Mar 15, 2010 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Actavis Labs Fl Inc | FENTANYL CITRATE | fentanyl citrate | TABLET;SUBLINGUAL | 207338-003 | Nov 17, 2017 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Actavis Labs Fl Inc | TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401-005 | Apr 10, 2003 | AB4 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
